Viaderma Stock Buy Hold or Sell Recommendation
| VDRM Stock | USD 0.01 0.0004 4.44% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Viaderma is 'Strong Sell'. The recommendation algorithm takes into account all of Viaderma's available fundamental, technical, and predictive indicators you will find on this site.
Check out Viaderma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Viaderma and provide practical buy, sell, or hold advice based on investors' constraints. Viaderma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Viaderma |
Execute Viaderma Buy or Sell Advice
The Viaderma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Viaderma. Macroaxis does not own or have any residual interests in Viaderma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Viaderma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Viaderma Trading Alerts and Improvement Suggestions
| Viaderma is way too risky over 90 days horizon | |
| Viaderma has some characteristics of a very speculative penny stock | |
| Viaderma appears to be risky and price may revert if volatility continues | |
| Viaderma has high likelihood to experience some financial distress in the next 2 years | |
| The company has a current ratio of 0.28, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Viaderma until it has trouble settling it off, either with new capital or with free cash flow. So, Viaderma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Viaderma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Viaderma to invest in growth at high rates of return. When we think about Viaderma's use of debt, we should always consider it together with cash and equity. | |
| Viaderma reported the previous year's revenue of 44.69 K. Net Loss for the year was (1.52 M) with profit before overhead, payroll, taxes, and interest of 37.63 K. | |
| Viaderma currently holds about 13.08 K in cash with (167.36 K) of positive cash flow from operations. |
Viaderma Returns Distribution Density
The distribution of Viaderma's historical returns is an attempt to chart the uncertainty of Viaderma's future price movements. The chart of the probability distribution of Viaderma daily returns describes the distribution of returns around its average expected value. We use Viaderma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Viaderma returns is essential to provide solid investment advice for Viaderma.
| Mean Return | 1.50 | Value At Risk | -16.67 | Potential Upside | 25.00 | Standard Deviation | 13.46 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Viaderma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Viaderma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Viaderma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Viaderma's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Viaderma pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.67 | |
β | Beta against Dow Jones | -1.61 | |
σ | Overall volatility | 12.74 | |
Ir | Information ratio | 0.10 |
Viaderma Volatility Alert
Viaderma is showing large volatility of returns over the selected time horizon. Viaderma is a penny stock. Even though Viaderma may be a good instrument to invest, many penny pink sheets are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Viaderma or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Viaderma instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Viaderma Fundamentals Vs Peers
Comparing Viaderma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Viaderma's direct or indirect competition across all of the common fundamentals between Viaderma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Viaderma or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Viaderma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Viaderma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Viaderma to competition |
| Fundamentals | Viaderma | Peer Average |
| Return On Asset | -0.91 | -0.14 |
| Operating Margin | (13.28) % | (5.51) % |
| Current Valuation | 6.18 M | 16.62 B |
| Shares Outstanding | 137.32 K | 571.82 M |
| Price To Earning | 0.03 X | 28.72 X |
| Price To Book | 0 X | 9.51 X |
| Price To Sales | 2.01 X | 11.42 X |
| Revenue | 44.69 K | 9.43 B |
| Gross Profit | 37.63 K | 27.38 B |
| EBITDA | (592.43 K) | 3.9 B |
| Net Income | (1.52 M) | 570.98 M |
| Cash And Equivalents | 13.08 K | 2.7 B |
| Debt To Equity | 20.90 % | 48.70 % |
| Current Ratio | 0.29 X | 2.16 X |
| Book Value Per Share | (0) X | 1.93 K |
| Cash Flow From Operations | (167.36 K) | 971.22 M |
| Earnings Per Share | 0.16 X | 3.12 X |
| Number Of Employees | 8 | 18.84 K |
| Beta | -0.42 | -0.15 |
| Market Capitalization | 82.27 K | 19.03 B |
| Total Asset | 426.56 K | 29.47 B |
| Retained Earnings | (7.38 M) | 9.33 B |
| Working Capital | (445 K) | 1.48 B |
| Current Asset | 185 K | 9.34 B |
| Current Liabilities | 630 K | 7.9 B |
| Z Score | -28.3 | 8.72 |
| Net Asset | 426.56 K |
Viaderma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Viaderma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 746786.0 | |||
| Daily Balance Of Power | 0.1667 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 0.0104 | |||
| Day Typical Price | 0.0101 | |||
| Price Action Indicator | (0.0008) | |||
| Period Momentum Indicator | 4.0E-4 | |||
| Relative Strength Index | 48.18 |
About Viaderma Buy or Sell Advice
When is the right time to buy or sell Viaderma? Buying financial instruments such as Viaderma Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Viaderma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Insurance Providers Thematic Idea Now
Insurance Providers
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Viaderma Pink Sheet
Viaderma financial ratios help investors to determine whether Viaderma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Viaderma with respect to the benefits of owning Viaderma security.